Rabourn Amy Zaremba - Jan 10, 2023 Form 4 Insider Report for Ocuphire Pharma, Inc. (OCUP)

Role: SVP of Finance
Signature: /s/ Emily J. Johns, by Power of Attorney
Stock symbol: OCUP
Transactions as of: Jan 10, 2023
Transactions value $: $0
Form type: 4
Date filed: 1/12/2023, 04:30 PM
Previous filing: Feb 1, 2022
Next filing: Jan 12, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OCUP	Common Stock	Award	$0	+46.6K		$0.00	46.6K	Jan 10, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OCUP	Employee Stock Option (right to buy)	Award	$0	+69.9K		$0.00	69.9K	Jan 10, 2023	Common Stock	69.9K	$3.50	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a grant of restricted stock units which vest in four equal installments on the first, second, third and fourth anniversary of the grant date of January 10, 2023.
F2	The option will vest with respect to 17,478 shares on January 10, 2024, with the balance vesting quarterly in twelve equal installments thereafter.